Cormorant Asset Management, LP - 10%+ Owner at Ambrx Biopharma Cayman, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: AMAM
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Cormorant Asset Management, LP since 12/22/2023

Holdings reported by Cormorant Asset Management, LP for Ambrx Biopharma Cayman, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Ordinary Shares	69.5M	$642M	$9.24	Sep 18, 2023	Indirect

Transactions reported by Cormorant Asset Management, LP for Ambrx Biopharma Cayman, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.